cardiovascular-devices-united-states-clinicals-pipeline-product-analysis-industry
Published

August 2016

Cardiovascular Devices - United States Clinicals Pipeline Product Analysis

Purchase Report
$3000
Single user license
$3500
Team license
$6250
Corporate license

More than 240 cardiovascular devices have been cleared for clinical trials as of May 2014 in the United States. Given the product development timeline, most devices in development are in the clinical stage, making it important for major players and new entrants alike to closely follow.

Over 120 companies have been covered in the study across various device areas including cardiac assist devices, cardiovascular monitoring and diagnostic devices, cardiac rhythm management devices, cardiovascular surgery devices, electrophysiology devices, interventional cardiology devices, peripheral vascular devices andb transcatheter heart valves.

RELATED REPORTS
No related reports available.
Purchase Report
$3000
Single user license
$3500
Team license
$6250
Corporate license
Our Clients Include View All

Looking to Customize Report?